Kezar Life Sciences Inc (KZR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,508 | -16,360 | -7,642 | -23,167 | -17,385 |
| Depreciation Amortization | 65 | -67 | -56 | 214 | 294 |
| Other Working Capital | -224 | 105 | 97 | 62 | 131 |
| Other Operating Activity | 3,000 | 1,910 | 901 | 2,099 | 1,641 |
| Operating Cash Flow | $-22,667 | $-14,412 | $-6,700 | $-20,792 | $-15,319 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -589 | -523 | -34 | -1,110 | -993 |
| Purchase Of Investment | -86,571 | -59,255 | -35,936 | -119,244 | -72,995 |
| Sale Of Investment | 105,901 | 62,896 | 36,946 | 36,450 | 0 |
| Investing Cash Flow | $18,741 | $3,118 | $976 | $-83,904 | $-73,988 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 192 | 184 | 4 | 77,913 | 77,908 |
| Financing Cash Flow | $192 | $184 | $4 | $77,913 | $77,908 |
| Exchange Rate Effect | -83 | -41 | 8 | -81 | -53 |
| Beginning Cash Position | 24,182 | 24,182 | 24,182 | 51,046 | 51,046 |
| End Cash Position | 20,365 | 13,031 | 18,470 | 24,182 | 39,594 |
| Net Cash Flow | $-3,817 | $-11,151 | $-5,712 | $-26,864 | $-11,452 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,667 | -14,412 | -6,700 | -20,792 | -15,319 |
| Capital Expenditure | -589 | -523 | -34 | -1,120 | -1,003 |
| Free Cash Flow | -23,256 | -14,935 | -6,734 | -21,912 | -16,322 |